MIAMI – HOPE Therapeutics, Inc., (‘HOPE,’ the ‘Company’), a medical and technology driven company, and a wholly-owned subsidiary of NRx Pharmaceuticals, Inc. (‘NRx’) (Nasdaq: NRXP), today announced the planned acquisition of the Kadima Neuropsychiatry Institute (Kadima) of La Jolla, CA, per the previously announced Letter of Intent, for the HOPE network. Kadima is expected to serve as the flagship clinic for HOPE’s…